le 11 janvier/January 2019

	The common shares of Cannara Biotech Inc., have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;<a href="https://thecse.com/en/listings/life-sciences/cannara-biotech-inc">www.thecse.com</a>&nbsp;on the trading date.

	&nbsp;

	Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. &nbsp;

	Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.

	________________________

	 
	Les actions ordinaires de Cannara Biotech Inc. ont été approuvées pour être inscrites à la CSE.

	Les documents de cotation et d'information seront disponibles sur <a href="https://thecse.com/fr/inscriptions/sciences-biologiques/cannara-biotech-inc">www.thecse.com</a> à la date de négociation.

	Cannara Biotech Inc. est une entreprise de cannabis à intégration verticale qui construit le plus grand établissement de culture de cannabis en intérieur au Québec, un établissement moderne et sécurisé de 625 000 pieds carrés.

	En exploitant les faibles coûts d’électricité du Québec, Cannara produira du cannabis d’intérieur de haute qualité, spécialisé dans les produits dérivés et les marques.
<table border="1" cellpadding="0" cellspacing="1" >
<tbody>
<tr>
<td >

					Issuer/Émetteur:
</td>
<td >

					Cannara Biotech Inc.
</td>
</tr>
<tr>
<td>

					Security Type/Titre:
</td>
<td>

					Common&nbsp;Shares/Actions&nbsp;ordinaires
</td>
</tr>
<tr>
<td>

					Symbol(s)/Symbole(s):
</td>
<td>
				LOVE</td>
</tr>
<tr>
<td>

					Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:
</td>
<td>
				693 820 705</td>
</tr>
<tr>
<td>

					Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:
</td>
<td>
				44 899 267</td>
</tr>
<tr>
<td>

					CSE Sector/Catégorie:
</td>
<td>
				Life Sciences/Sciences biologiques</td>
</tr>
<tr>
<td>

					CUSIP:
</td>
<td>
				13765U 10 1</td>
</tr>
<tr>
<td>

					ISIN:
</td>
<td>
				CA 13765U 10 1 2</td>
</tr>
<tr>
<td>

					Boardlot/Quotité:
</td>
<td>
				500</td>
</tr>
<tr>
<td>

					Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:
</td>
<td>

					CDN$/$CDN
</td>
</tr>
<tr>
<td>
				Trading Date/Date de&nbsp;negociation:</td>
<td>
				le 14 janvier/January 2019</td>
</tr>
<tr>
<td>

					Other Exchanges/Autres&nbsp;marches:
</td>
<td>

					N/A
</td>
</tr>
<tr>
<td>

					Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:
</td>
<td>

					Le 31 août/August
</td>
</tr>
<tr>
<td>

					Transfer Agent/Agent des&nbsp;transferts:
</td>
<td>
				Computershare Investor Services Inc.</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for LOVE. Please email: <a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

Cannara Biotech Inc.

2019-0111 – New Listing - Cannara Biotech Inc. (LOVE)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.